4.6 Review

Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000-2016: a systematic review and meta-analysis

期刊

INFECTION
卷 45, 期 3, 页码 309-321

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s15010-016-0975-y

关键词

Hepatitis C; HIV; Men having sex with men; Meta-analysis; Prospective study; Retrospective study

资金

  1. AbbVie
  2. Boehringer Ingelheim
  3. Bristol Myers Squibb
  4. Gilead Sciences
  5. Janssen
  6. Merck Sharp Dome
  7. Pfizer
  8. Roche
  9. ViiV Healthcare
  10. University of Zurich's Clinical research Priority Program (CRPP)

向作者/读者索取更多资源

There is a need for systematic reviews and meta-analyses to synthesize the epidemiology, and the riskfactors for hepatitis C virus (HCV) among HIV-coinfected and HIV negative men who have sex with men (MSM). A meta-analysis of 28 studies was carried out by pooling HCV incidence data of HIV-coinfected and HIV negative MSM. Differences in incidence outcome depending on the prospective or retrospective nature of the individual studies were investigated. The pooled incidence of HCV in MSM was 6.3 per 1000 person-years (95% CI 5.0-7.5). The overall estimated incidence was 19-fold higher in HIV positive compared to HIV negative MSM living in resource-rich countries. This result was confirmed when the analysis was restricted to high-quality studies. Factors associated with an increased risk for incident HCV included behavioural factors (sexual risk behaviour and recreational drug use) as well as biological characteristics (HIV coinfection and a recent history of syphilis). In conclusion, incident HCV predominantly affects HIV positive MSM. The incidence rate varied largely between studies, factors such as study design might play an important role.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据